Paul Mueller Company Announces Its First Quarter Earnings of 2024


SPRINGFIELD, Mo., April 26, 2024 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended March 31, 2024.

PAUL MUELLER COMPANY
THREE-MONTH REPORT
(In thousands)
         
CONSOLIDATED STATEMENTS OF INCOME
         
  Three Months Ended Twelve Months Ended
  March 31 March 31
  2024 2023 2024 2023
         
Net Sales $50,356 $56,351 $223,161 $207,096
Cost of Sales 34,560 39,554 153,631 159,979
Gross Profit $15,796 $16,797 $69,530 $47,117
Selling, General and Administrative Expense10,358 12,587 86,040 37,358
Operating Income (Loss) $5,438 $4,210 $(16,510) $9,759
Interest Expense (1,248) (97) (1,501) (406)
Other Income 1,544 720 3,491 1,571
Income (Loss) before Provision (Benefit) for Income Taxes$5,734 $4,833 $(14,520) $10,924
Provision (Benefit) for Income Taxes 1,285 1,166 (5,413) 2,526
Net Income (Loss) $4,449 $3,667 $(9,107) $8,398
         
Earnings (Loss) per Common Share ––Basic and Diluted$4.10 $3.38 $(8.39) $7.74
         


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
          
       Three Months Ended
       March 31
       2024 2023
          
Net Income     $4,449 $3,667
Other Comprehensive Income (Loss), Net of Tax:      
Foreign Currency Translation Adjustment   (239) 164
Comprehensive Income   $4,210 $3,831
          


CONSOLIDATED BALANCE SHEETS
          
       March 31 December 31
       2024 2023
          
Cash      $5,644 $1,883
Marketable Securities     31,687 32,042
Accounts Receivable     25,209 25,166
Inventories (FIFO)     47,689 45,910
LIFO Reserve      (21,557) (21,774)
Inventories (LIFO)     26,132 24,136
Current Net Investments in Sales-Type Leases   28 27
Other Current Assets     7,344 3,537
Current Assets $96,044 $86,791
          
Net Property, Plant, and Equipment 42,854 42,011
Right of Use Assets     2,322 2,421
Other Assets 2,372 2,590
Long-Term Net Investments in Sales-Type Leases   480 456
Total Assets $144,072 $134,269
          
Accounts Payable     $11,993 $11,041
Current Maturities and Short-Term debt     632 640
Current Lease Liabilities     364 402
Advance Billings      33,434 27,383
Pension Liabilities     32 32
Other Current Liabilities     18,722 19,599
Current Liabilities $65,177 $59,097
          
Long-Term Debt     8,616 8,880
Long-Term Pension Liabilities     225 233
Other Long-Term Liabilities 1,775 1,768
Lease Liabilities      722 775
Total Liabilities     $76,515 $70,753
Shareholders' Investment 67,557 63,516
Total Liabilities and Shareholders' Investment $144,072 $134,269
          


 
SELECTED FINANCIAL DATA
        March 31 December 31
        2024 2023
Book Value per Common Share     $62.22 $58.50
Total Shares Outstanding     1,085,711 1,085,711
Backlog       $95,196 $97,350
           


 CONSOLIDATED STATEMENT OF SHAREHOLDERS' INVESTMENT  
              Accumulated Other Comprehensive Income (Loss)  
                 
      Common Stock Paid-in Surplus Retained Earnings Treasury Stock    
           Total
Balance, December 31, 2023  $1,508 $9,708 $67,181 $(10,787) $(4,094) $63,516
Add (Deduct):              
 Net Income      4,449     4,449
 Other Comprehensive (Loss) Net of Tax         (239) (239)
 Dividends, $.60 per Common Share     (163)     (163)
 Other        $(6)     (6)
Balance, March 31, 2024  $1,508 $9,708 $71,461 $(10,787) $(4,333) $67,557
                 


 CONSOLIDATED STATEMENT OF CASH FLOWS
 Three Months
Ended
March 31, 2024
 Three Months
Ended March 31,
2023
  
  
  
Operating Activities:   
    
Net Income$4,449 $3,667
    
Adjustment to Reconcile Net Income to Net Cash Provided by Operating Activities:   
Pension Contributions (Greater) Less than Expense(8) (409)
Bad Debt Expense- 15
Depreciation & Amortization1,736 1,560
Loss (Gain) on Disposal of Equipment18 9
Change in Assets and Liabilities   
(Inc) in Accts and Notes Receivable(42) (2,634)
(Inc) in Cost in Excess of Estimated Earnings and Billings(35) -
(Inc) in Inventories(1,901) -
(Inc) in Prepayments(3,772) (2,937)
(Inc) in Net Investment in Sales-Type Leases(25) (1,122)
Dec (Inc) in Other Assets469 (46)
Dec in Deferred Taxes- 240
(Dec) Inc in Accounts Payable952 (204)
Inc in Accrued Income Tax1,501 430
Inc (Dec) in Accrued Expenses(654) 3,622
(Dec) Inc in Advanced Billings6,051 (1,088)
(Dec) in Billings in Excess of Costs and Estimated Earnings(1,730) (736)
Inc in Lease Liability for Operating24 -
Inc in Lease Liability for Financing- 131
Principal payments on Lease Liability for Operating(41) (65)
(Dec) in Long Term Liabilities(12) (58)
(Dec) in Long Term Deferred Tax Liabilities(82) -
        Net Cash Provided by Operating Activities$6,898 $375
    
Investing Activities   
Intangibles- (62)
Proceeds from Sales of Equipment15 2
Purchases in Marketable Securities(12,221) (5,676)
Proceeds from Sales of Marketable Securities12,575 8,496
Additions to Property, Plant, and Equipment(3,064) (1,589)
       Net Cash (Required) for Investing Activities$(2,695) $1,171
    
Financing Activities   
Principal payments on Lease Liability for Financing(52) (46)
Proceeds from Short-Term Borrowings277 1,407
(Repayment) of Short-Term Borrowings(277) (1,407)
(Repayment) of Long-Term Debt(158) (158)
Dividends paid(163) (163)
       Net Cash (Required) for Financing Activities$(373) $(367)
    
Effect of Exchange Rate Changes (69) 64
    
Net Increase in Cash $3,761 $1,243
    
Cash at Beginning of Year1,883 679
    
Cash at End of Quarter$5,644 $1,922
    

 

PAUL MUELLER COMPANY
SUMMARIZED NOTES TO THE FINANCIAL STATEMENTS
(In thousands)

A. The chart below depicts the net revenue on a consolidating basis for the three months ended March 31.

Three Months Ended March 31
Revenue 2024  2023 
Domestic$38,877 $45,585 
Mueller BV$11,825 $11,304 
Eliminations$(346)$(538)
Net Revenue$50,356 $56,351 
   

The chart below depicts the net revenue on a consolidating basis for the twelve months ended March 31.

Twelve Months Ended March 31
Revenue 2024  2023 
Domestic$176,298 $162,662 
Mueller BV$48,231 $45,680 
Eliminations$(1,368)$(1,246)
Net Revenue$223,161 $207,096 
   

The chart below depicts the net income (loss) on a consolidating basis for the three months ended March 31.

Three Months Ended March 31
Net Income 2024  2023 
Domestic$4,048 $4,450 
Mueller BV$374 $(770)
Eliminations$27 $(13)
Net Income$4,449 $3,667 
   

The chart below depicts the net income on a consolidating basis for the twelve months ended March 31.

Twelve Months Ended March 31
Net Income 2024  2023 
Domestic$(11,730)$9,852 
Mueller BV$2,621 $(1,435)
Eliminations$2 $(19)
Net Income (Loss)$(9,107)$8,398 
       

B.  March 31, 2024 backlog is $95.2 million compared to $122.8 million at March 31, 2023. The majority of this backlog is in the U.S. where the backlog is $87.8 million at March 31, 2024 compared to $115.4 million at March 31, 2023. The $27.6 million reduction in U.S. backlog is from all segments but primarily from the pharmaceutical, food and beverage, and component divisions coming off of record high backlogs. In the Netherlands, the backlog is relatively flat -- $7.9 million at March 31, 2024 versus $8.2 million on March 31, 2023.

C.  Revenue is down from the previous year by $6 million on a three-month basis but up $16.1 million on trailing twelve months. The lower first quarter revenue from last year is primarily from the timing of revenue recognition on the larger pharmaceutical projects and lower revenue from the components division coming off record revenue in late 2022 and early 2023. In the Netherlands, revenue is above last year by $0.5 million and $2.1 million on a three-month and twelve-month basis, respectively. The Dutch market is improving.

Net Income is up $0.8 million on a three-month and down $17.5 million on a twelve-month basis before removing the pension settlement charges. In the Netherlands, earnings are up year over year by $1.1 million for three months and $4.1 million over twelve months. One-time restructuring charges accrued in March 2023 and the subsequent efficiencies achieved from the restructuring along with a price increase taken in the first quarter of 2023 on slightly higher volumes led to the improved earnings.

We manage our business in the U.S. looking at earnings before tax (EBT) and excluding the effects of LIFO and non-reoccurring events such as the pension settlement. This non-GAAP adjusted EBT (as shown in the table below) is down $0.7 million for the three months but up $9.7 million for the trailing twelve months primarily from strong results in the pharmaceutical, food and beverage, and components divisions.

 Three Months Ended March 31 Twelve Months Ended March 31
(In Thousands) 2024  2023   2024  2023 
Domestic Net Income$4,048 $4,450  $(11,730)$9,852 
Income Tax Expense$1,171 $1,405  $(4,991)$3,020 
Domestic EBT - GAAP$5,219 $5,855  $(16,721)$12,872 
LIFO Adjustment$(217)$(185) $51 $2,577 
Pension Adjustment$- $-  $41,774 $- 
Domestic EBT - Non-GAAP$5,002 $5,670  $25,104 $15,449 
              

D.   On March 12, 2024, the Board of Directors authorized a tender offer effective from March 15, 2024, through May 7, 2024, for up to $10 million with the option to go to $15 million of the Company’s common stock at a price of $80. As of April 26, 2024, $5.88 million in shares are tendered to the Company’s depository agent. On April 26, 2024, the Company announced that the limit was increased to $15 million.

E.   Effective March 14, 2024, the Company amended its domestic bank borrowing facility to extend the agreement until March 31, 2025, with the following changes:

  1. Capacity was reduced from $15 million to $10 million.
  2. Interest rate spread was changed from “SOFR+10” plus 1.15% to “SOFR+10” plus 1.35%.
  3. Financial leverage test of trailing twelve-month Debt/EBITDA was eliminated.

F.   The pre-tax results for the three months ended March 31, 2024, were favorably affected by $0.2 million decrease in the LIFO reserve. The pre-tax results for the twelve months ended March 31, 2024, were unfavorably affected by $0.1 million increase in the LIFO reserve. The pre-tax results for the three months ended March 31, 2023, were favorably affected by $0.2 million increase in the LIFO reserve. The pre-tax results for the twelve months ended March 31, 2023 were unfavorably affected by $2.6 million increase in the LIFO reserve.

G.   The consolidated financials are affected by the euro to dollar exchange rate when consolidating Mueller B.V., the Dutch subsidiary. The month-end euro to dollar exchange rate was 1.09 for March 2023, 1.10 for December 2023, and 1.08 for March 2024, respectively.

This press release contains forward-looking statements that provide current expectations of future events based on certain assumptions. All statements regarding future performance growth, conditions, or developments are forward-looking statements. Actual future results may differ materially from those described in the forward-looking statements due to a variety of factors, including, but not limited to, the factors described in the Company’s Annual Report under “Safe Harbor for Forward-Looking Statements”, which is available at paulmueller.com. The Company expressly disclaims any obligation or undertaking to update these forward-looking statements to reflect any future events or circumstances.

The accounting policies related to this report and additional management discussion and analysis are provided in the 2023 annual report, available at
www.paulmueller.com.

Press Contact: Ken Jeffries | Paul Mueller Company | Springfield, MO 65802 | (417) 575-9346
kjeffries@paulmueller.com | http://paulmueller.com



Tags